An Open-label, Randomized, Three-period, Crossover Study to Assess the Effect of Food and Calcium on S-888711 0.25-mg Tablet Pharmacokinetics in Healthy, Adult Volunteer Subjects Following a Single 0.75-mg Oral Dose of S-888711
Latest Information Update: 17 Jan 2020
Price :
$35 *
At a glance
- Drugs Lusutrombopag (Primary)
- Indications Thrombocytopenia
- Focus Pharmacokinetics
- Sponsors Shionogi
- 11 Jul 2019 Results of three studies (JapicCTI-194690, JapicCTI-194689, NCT03897413) assessing the effect of food and calcium carbonate on the pharmacokinetic profile of lusutrombopag in healthy subjects published in the Clinical Therapeutics
- 05 Apr 2019 New trial record